Corient Private Wealth LP Trims Holdings in Lam Research Corporation $LRCX

Corient Private Wealth LP lowered its holdings in shares of Lam Research Corporation (NASDAQ:LRCX) by 4.3% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,058,347 shares of the semiconductor company’s stock after selling 47,550 shares during the period. Corient Private Wealth LP’s holdings in Lam Research were worth $458,340,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Brighton Jones LLC raised its holdings in shares of Lam Research by 1,032.4% in the fourth quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company’s stock valued at $1,025,000 after buying an additional 12,936 shares during the last quarter. Caxton Associates LLP acquired a new stake in shares of Lam Research during the first quarter worth about $239,000. Gabelli Funds LLC purchased a new position in shares of Lam Research during the second quarter worth about $253,000. NewEdge Advisors LLC increased its position in Lam Research by 2.7% in the 2nd quarter. NewEdge Advisors LLC now owns 100,528 shares of the semiconductor company’s stock valued at $9,785,000 after acquiring an additional 2,661 shares during the period. Finally, Osterweis Capital Management Inc. increased its position in Lam Research by 5,206.7% in the 2nd quarter. Osterweis Capital Management Inc. now owns 796 shares of the semiconductor company’s stock valued at $77,000 after acquiring an additional 781 shares during the period. 84.61% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other Lam Research news, Director Abhijit Y. Talwalkar sold 18,282 shares of the stock in a transaction dated Monday, July 13th. The shares were sold at an average price of $335.00, for a total value of $6,124,470.00. Following the completion of the transaction, the director directly owned 87,142 shares of the company’s stock, valued at approximately $29,192,570. This trade represents a 17.34% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Neil J. Fernandes sold 7,659 shares of the stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $309.60, for a total transaction of $2,371,226.40. Following the completion of the transaction, the senior vice president directly owned 58,470 shares of the company’s stock, valued at approximately $18,102,312. This trade represents a 11.58% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 80,441 shares of company stock worth $27,614,296 in the last 90 days. 0.31% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on LRCX shares. Barclays reaffirmed an “overweight” rating and set a $335.00 price objective (up from $275.00) on shares of Lam Research in a research report on Thursday, June 11th. B. Riley Financial dropped their target price on Lam Research from $385.00 to $350.00 and set a “buy” rating on the stock in a report on Thursday, July 30th. Evercore restated an “outperform” rating and set a $355.00 price target on shares of Lam Research in a research note on Monday, July 20th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $320.00 price target on shares of Lam Research in a report on Thursday, July 30th. Finally, Raymond James Financial set a $425.00 price objective on shares of Lam Research in a research report on Wednesday, June 10th. One analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, Lam Research presently has a consensus rating of “Moderate Buy” and a consensus price target of $357.31.

Key Headlines Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: AI-focused R&D expansion: Lam Research broke ground on a 120,000-square-foot laboratory in Tualatin, Oregon, as part of a planned investment of more than $3 billion in its global lab network over the next five years. The facility is intended to support collaboration with chipmakers and accelerate equipment innovations for advanced AI semiconductors. Lam Research Oregon lab announcement
• Positive Sentiment: Strong AI demand outlook: CEO Tim Archer said increasingly complex AI models require more computing power, bandwidth and storage, creating demand for semiconductor innovation. The investment reinforces Lam’s positioning as a supplier to the AI infrastructure buildout. Lam Research AI investment video
• Positive Sentiment: Favorable analyst and fundamentals commentary: Zacks highlighted AI-driven growth, recurring services revenue, earnings momentum and Lam’s balance sheet, while Mizuho maintained an “outperform” rating despite trimming its price target to $365 from $370. Lam’s latest reported quarter also showed 30% year-over-year revenue growth and an earnings beat.
• Neutral Sentiment: Investor outreach scheduled: CFO Doug Bettinger will participate in upcoming investor conferences. The events could provide updates on demand, AI exposure and the Oregon investment, but no new financial guidance was announced. Lam Research conference announcement
• Negative Sentiment: Investment and valuation concerns: The multibillion-dollar R&D expansion will raise near-term capital and operating costs, while the stock’s high earnings multiple leaves less room for disappointment. The modest analyst price-target reduction may also have limited enthusiasm.

Lam Research Stock Down 0.6%

Lam Research stock opened at $312.88 on Thursday. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.63 and a quick ratio of 1.91. Lam Research Corporation has a 1-year low of $94.11 and a 1-year high of $438.50. The company has a market cap of $391.51 billion, a PE ratio of 54.32, a price-to-earnings-growth ratio of 1.25 and a beta of 1.84. The stock’s 50 day moving average price is $333.58 and its 200 day moving average price is $288.43.

Lam Research (NASDAQ:LRCX) last released its earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 EPS for the quarter, beating analysts’ consensus estimates of $1.69 by $0.13. The company had revenue of $6.72 billion during the quarter, compared to the consensus estimate of $6.66 billion. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.Lam Research’s quarterly revenue was up 30.0% compared to the same quarter last year. During the same quarter last year, the company earned $1.33 earnings per share. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. On average, sell-side analysts predict that Lam Research Corporation will post 9.32 EPS for the current fiscal year.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.